Aastrom BioSciences hires new CEO, plans to hire 5

Thursday, January 14, 2010 | Source: Concentrate

Aastrom BioSciences might have been around the block a few times in the Ann Arbor drug development scene, but it has a new product with the promise of becoming a ground breaking innovation – stem cell therapy.

Excerpt:

One of Ann Arbor's older bio-tech firms is looking to make room for some new hires this year now that it has brought on new leadership.

Domino's Farms-based Aastrom BioSciences recently hired Tim Mayleben as its new CEO, CFO and president. He will lead the company through developing its new product, a stem cell therapy for cardiovascular patients that uses their own stem cells.

"It is able to change the course of the disease so the patients feel better and do better," Mayleben says.

Read the rest of the story here.